Detalles de la búsqueda
1.
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
Gastroenterology
; 157(3): 760-776, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31063779
2.
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Int J Cancer
; 145(7): 1902-1912, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859564
3.
Analytical Platforms 1: Use of Cultured Cells and Fluorescent Read-Out Coupled to NormaCurve Normalization in RPPA.
Adv Exp Med Biol
; 1188: 77-93, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820384
4.
Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
Br J Cancer
; 119(3): 387, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29899390
5.
Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.
Br J Cancer
; 117(12): 1819-1827, 2017 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024937
6.
Proliferation Genes Repressed by TGF-ß Are Downstream of Slug/Snail2 in Normal Bronchial Epithelial Progenitors and Are Deregulated in COPD.
Stem Cell Rev Rep
; 17(3): 703-718, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33495975
7.
PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?
Clin Res Hepatol Gastroenterol
; 45(5): 101553, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33183998
8.
Integrative analysis of multi-platform reverse-phase protein array data for the pharmacodynamic assessment of response to targeted therapies.
Sci Rep
; 10(1): 21985, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33319783
9.
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Theranostics
; 10(4): 1531-1543, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042320
10.
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.
Cancers (Basel)
; 11(6)2019 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31146482
11.
Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition.
Oncotarget
; 9(51): 29587-29600, 2018 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30038706
Resultados
1 -
11
de 11
1
Próxima >
>>